Tudor Investment Corp
APGE icon

Tudor Investment Corp’s Apogee Therapeutics APGE Stock Holding History

Tudor Investment Corp’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,039
Closed -$2.27M – 3566
2025
Q4 		$2.27M Buy
+30,039
New +$1.89M ﹤0.01% 1724
2024
Q2 		– Sell
-12,522
Closed -$832K – 2293
2024
Q1 		$832K Buy
+12,522
New +$547K 0.01% 1420
2023
Q4 		– Sell
-12,515
Closed -$267K – 2340
2023
Q3 		$267K Buy
+12,515
New +$276K ﹤0.01% 1971

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Tudor Investment Corp's APGE Position: Q1 2026 in Review

Tudor Investment Corp sold out of Apogee Therapeutics (APGE) in Q1 2026, closing a stake of 30,039 shares — an estimated $2.27M sold.

Tudor Investment Corp first reported a position in APGE in Q3 2023 and held it in 3 quarters. The position peaked at $2.27M in Q4 2025. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Tudor Investment Corp reported no remaining Apogee Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 30,039 Apogee Therapeutics shares in Q1 2026, an estimated $2.27M.
  • Tudor Investment Corp first reported a position in Apogee Therapeutics in Q3 2023 and held it in 3 quarters.
  • Tudor Investment Corp's Apogee Therapeutics position peaked at $2.27M in Q4 2025.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.